全自动MRI影像组学鉴别胰腺腺鳞癌与导管腺癌
混合模型在训练集和验证集AUC分别为0.94和0.96,验证集敏感度67.57%、特异度97.44%、准确率90.26%,优于临床模型(p=0.001)和影像组学模型(p=0.04)。
要点
- 混合模型鉴别PASC与PDAC验证集AUC 0.96,特异度高(97.44%)但敏感度中等(67.57%)。
- 全自动深度学习分割可重复提取MRI影像组学特征,减少人工勾画变异。
- 混合模型预测为PDAC组生存期显著长于预测PASC组(p=0.003)。
局限性
- 单中心回顾性研究,外部泛化性需多中心验证。
- 敏感度偏低(验证集67.57%),可能漏诊部分PASC。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop and validate an automated magnetic resonance imaging (MRI)-based model to preoperatively differentiate pancreatic adenosquamous carcinoma (PASC) from pancreatic ductal adenocarcinoma (PDAC).
METHODS: This retrospective study included patients with surgically resected, histopathologically confirmed PASC or PDAC who underwent MRI between January 2011 and December 2020. According to time of treatment, they were divided into training and validation sets. Automated deep-learning-based artificial intelligence was used for pancreatic tumor segmentation. Linear discriminant analysis was performed with conventional MRI and radiomic features to develop clinical, radiomics, and mixed models in the training set. The models' performances were determined from their discrimination and clinical utility. Kaplan-Meier and log-rank tests were used for survival analysis.
RESULTS: Overall, 389 and 123 patients with PDAC (age, 61.37 ± 9.47 years; 251 men) and PASC (age, 61.99 ± 9.82 years; 78 men) were included, respectively; they were split into the training (n = 358) and validation (n = 154) sets. The mixed model showed good performance in the training and validation sets (area under the curve: 0.94 and 0.96, respectively). The sensitivity, specificity, and accuracy were 76.74%, 93.38%, and 89.39% for the training set, respectively, and 67.57%, 97.44%, and 90.26% for the validation set, respectively. The mixed model outperformed the clinical (p = 0.001) and radiomics (p = 0.04) models in the validation set. Log-rank test revealed significantly longer survival in the predicted PDAC group than in the predicted PASC group (p = 0.003), according to the mixed model.
CONCLUSION: Our mixed model, which combined MRI and radiomic features, can be used to differentiate PASC from PDAC.
引用
- Li, Zhou, Chen, et al. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2023. PMID: 36964775. doi:10.1007/s00261-023-03801-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。